Integra LifeSciences  Corporation logo

Integra LifeSciences Corporation

IART | NASDAQ
Chart Builder DCF Calculator
$16.17
+$0.58 (+3.72%)
Sep 22, 2026, 11:27 AM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
-516.47M -6.94M 67.74M 180.55M 169.08M 133.89M
Depreciation & Amortization
151.83M 140.89M 123.51M 118.3M 119.84M 116.03M
Stock-Based Compensation
18.58M 24.38M 20.14M 27.73M 36.21M 19.59M
Other Working Capital
-13.22M -7.58M -6.17M 6.27M -27.35M 12.44M
Other Non-Cash Items
496.44M 22.79M 22.02M -18.1M -28.1M 39.77M
Deferred Income Tax
-66.26M -20.73M -11.89M -4.59M -2.76M -64.14M
Change in Working Capital
-33.74M -31.01M -81.57M -39.42M 18.16M -41.31M
Operating Cash Flow
50.38M 129.38M 139.96M 264.47M 312.43M 203.83M
Capital Expenditures
-95.64M -104.42M -66.87M -47.09M -48.08M -63.89M
Cash Acquisitions
n/a -277.81M n/a -27.55M -113.44M 3.66M
Purchase of Investments
-19.43M -49M -32.69M -4.91M n/a -7.84M
Sales Maturities Of Investments
7M 54.5M 5.38M 4.91M 76K -3.66M
Other Investing Acitivies
-14.2M -14.08M n/a 16.05M -55K 3.66M
Investing Cash Flow
-108.06M -390.81M -94.18M -58.58M -161.44M -68.07M
Debt Repayment
46.75M 299.37M 54.5M -107.8M -100M 305.5M
Common Stock Repurchased
-221K -52.47M -275M -125M n/a -100M
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-19.15M -9.04M -9.43M -24.62M -5.05M -78.8M
Financial Cash Flow
28.34M 237.86M -229.93M -251.95M -98.23M 121.63M
Net Cash Flow
-11.33M -30.03M -180.26M -56.79M 43.28M 271.26M
Free Cash Flow
-45.25M 24.96M 73.09M 217.38M 264.35M 139.94M
Adj. Free Cash Flow
-63.84M 587K 52.95M 189.66M 228.14M 120.35M
Maintenance CapEx
-88.09M -84.9M -66.87M -43.22M -6.3M -63.89M
Growth CapEx
-7.55M -19.52M n/a -3.87M -41.78M n/a
Owner Earnings
-37.71M 44.49M 73.09M 221.25M 306.13M 139.94M

© 2026 bestshares.com. All rights reserved.